Jessica Fye
Stock Analyst at J.P. Morgan
(4.41)
# 1,238
Out of 4,685 analysts
603
Total ratings
56%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMRN Amarin Corporation | Initiated Coverage: Sell | $10 → $13 | $14.07 | -7.60% | 11 | Aug 21, 2026 | |
| EBS Emergent BioSolutions | Initiated Coverage: Sell | n/a | $5.94 | - | 14 | Aug 21, 2026 | |
| NKTR Nektar Therapeutics | Initiated Coverage: Hold | $30 → $65 | $74.55 | -12.81% | 32 | Aug 21, 2026 | |
| MRNA Moderna | Maintained: Sell | $40 → $77 | $142.77 | -46.07% | 24 | Aug 21, 2026 | |
| STOK Stoke Therapeutics | Initiated Coverage: Buy | $25 → $40 | $32.59 | +22.74% | 18 | Aug 21, 2026 | |
| IMCR Immunocore Holdings | Initiated Coverage: Buy | $50 | $36.75 | +36.05% | 15 | Aug 21, 2026 | |
| MBX MBX Biosciences | Initiated Coverage: Buy | $88 | $66.39 | +32.55% | 4 | Aug 21, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $300 | $249.36 | +20.31% | 49 | Aug 19, 2026 | |
| BNTX BioNTech SE | Maintained: Hold | n/a | $111.40 | - | 32 | Aug 19, 2026 | |
| AKTS Aktis Oncology | Rated: Buy | $33 | $26.18 | +26.05% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $24.67 | +17.55% | 18 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 | $99.75 | +18.30% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $179 → $175 | $121.39 | +44.16% | 28 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $76 | $62.43 | +21.74% | 33 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $375 | $236.56 | +58.52% | 28 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $276 | $251.10 | +9.92% | 34 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 → $120 | $127.74 | -6.06% | 26 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $60 → $61 | $48.90 | +24.74% | 15 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $685 → $687 | $527.91 | +30.14% | 34 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $425 | $372.49 | +14.10% | 14 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $13 → $12 | $9.87 | +21.58% | 19 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 → $17 | $17.99 | -5.50% | 15 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $76 → $35 | $20.50 | +70.73% | 13 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $65.29 | - | 16 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 → $65 | $106.92 | -39.21% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.26 | - | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $517 → $530 | $547.55 | -3.21% | 21 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $52 | $84.85 | -38.72% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $14 | $29.01 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $2.32 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $19 | $1.80 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.8601 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $111.54 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $66 | $150.75 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.05 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $13.80 | n/a | 4 | Feb 8, 2018 |
Amarin Corporation
Aug 21, 2026
Initiated Coverage: Sell
Price Target: $10 → $13
Current: $14.07
Upside: -7.60%
Emergent BioSolutions
Aug 21, 2026
Initiated Coverage: Sell
Price Target: n/a
Current: $5.94
Upside: -
Nektar Therapeutics
Aug 21, 2026
Initiated Coverage: Hold
Price Target: $30 → $65
Current: $74.55
Upside: -12.81%
Moderna
Aug 21, 2026
Maintained: Sell
Price Target: $40 → $77
Current: $142.77
Upside: -46.07%
Stoke Therapeutics
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $25 → $40
Current: $32.59
Upside: +22.74%
Immunocore Holdings
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $36.75
Upside: +36.05%
MBX Biosciences
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $66.39
Upside: +32.55%
Ascendis Pharma
Aug 19, 2026
Maintained: Buy
Price Target: $300
Current: $249.36
Upside: +20.31%
BioNTech SE
Aug 19, 2026
Maintained: Hold
Price Target: n/a
Current: $111.40
Upside: -
Aktis Oncology
Aug 14, 2026
Rated: Buy
Price Target: $33
Current: $26.18
Upside: +26.05%
Aug 11, 2026
Maintained: Buy
Price Target: $29
Current: $24.67
Upside: +17.55%
Aug 11, 2026
Maintained: Buy
Price Target: $118
Current: $99.75
Upside: +18.30%
Aug 10, 2026
Rated: Buy
Price Target: $179 → $175
Current: $121.39
Upside: +44.16%
Aug 10, 2026
Rated: Buy
Price Target: $76
Current: $62.43
Upside: +21.74%
Aug 4, 2026
Maintained: Buy
Price Target: $375
Current: $236.56
Upside: +58.52%
Aug 4, 2026
Rated: Buy
Price Target: $276
Current: $251.10
Upside: +9.92%
Jul 30, 2026
Rated: Hold
Price Target: $110 → $120
Current: $127.74
Upside: -6.06%
Jul 29, 2026
Rated: Hold
Price Target: $60 → $61
Current: $48.90
Upside: +24.74%
Jul 23, 2026
Maintained: Buy
Price Target: $685 → $687
Current: $527.91
Upside: +30.14%
Jul 23, 2026
Maintained: Buy
Price Target: $425
Current: $372.49
Upside: +14.10%
Jul 13, 2026
Initiated Coverage: Hold
Price Target: $13 → $12
Current: $9.87
Upside: +21.58%
Jul 13, 2026
Maintained: Hold
Price Target: $23 → $17
Current: $17.99
Upside: -5.50%
Jul 13, 2026
Initiated Coverage: Hold
Price Target: $76 → $35
Current: $20.50
Upside: +70.73%
Oct 27, 2025
Maintained: Buy
Price Target: n/a
Current: $65.29
Upside: -
Oct 27, 2025
Maintained: Hold
Price Target: $63 → $65
Current: $106.92
Upside: -39.21%
Oct 13, 2025
Maintained: Buy
Price Target: n/a
Current: $59.26
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: $517 → $530
Current: $547.55
Upside: -3.21%
Sep 24, 2025
Reiterated: Buy
Price Target: $53 → $52
Current: $84.85
Upside: -38.72%
Jun 7, 2022
Maintained: Hold
Price Target: $18 → $14
Current: $29.01
Upside: n/a
Apr 7, 2022
Maintained: Hold
Price Target: $7 → $5
Current: $2.32
Upside: n/a
Mar 14, 2022
Maintained: Buy
Price Target: $20 → $19
Current: $1.80
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.8601
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $111.54
Upside: n/a
Apr 6, 2020
Maintained: Hold
Price Target: $94 → $66
Current: $150.75
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $9.05
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $13.80
Upside: n/a